NOVEL MARKERS FOR IMAGING GENE EXPRESSION IN VIVO USING MRI
NOVEL MARKERS FOR IMAGING GENE EXPRESSION IN VIVO USING MRI
批准号:
7252431
负责人:
ERIC T. AHRENS
金额:
$31.16万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-07 至 2009-06-30
关键词:
Adenovirus VectorAdenovirusesAffectBiochemicalBiologicalBiomedical ResearchBrainCell physiologyCellsChemicalsClassCodeComplementary DNAContrast MediaCultured CellsDiseaseFerritinFutureGene ExpressionGenerationsGeneticGenetic MedicineGenetics and MedicineGoalsHistocompatibility TestingHistopathologyHomologous GeneImageIn SituIn VitroInjection of therapeutic agentInstructionInvasiveIronLaboratoriesLengthLifeLocationMagnetic Resonance ImagingMeasuresMedicineMetalloproteinsMethodsMissionMolecular MedicineMusNeuraxisNoiseNumbersOrganismPathologicPhenotypePhysiologicalPreclinical TestingPropertyProteinsProtocols documentationPurposeRateReaction TimeRecombinantsRegulationRelaxationReporterReporter GenesReportingResearch PersonnelSimplexvirusSpecificityTechnologyTestingTissuesToxic effectTransgenesTransgenic AnimalsTransgenic ModelUnited States National Institutes of HealthVesicular stomatitis Indiana virusViral Vectorbasebrain tissuecell typecellular transductiondesigndesiredosagedrug developmentestablished cell lineimprovedin vivometal complexmolecular imagingnew technologynovelpre-clinicalprogramspromoterrecombinant virusresearch studysuccesstechnology developmenttherapeutic genetooltransgene expressionuptakevector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The ability to non-invasively image the duration and location of gene expression in vivo is important for the future of biomedical research and molecular medicine. The goal of this application is to develop a general purpose MRI reporter gene cassette that can be used in a variety of molecular imaging applications. Recent results from our laboratory demonstrate that vectors encoding metalloprotein reporters delivered into the living mouse brain can elicit potent contrast in MR images. The reporter protein is made superparamagnetic as the cell sequesters endogenous iron from the organism. Our approach is unique because the cell constructs the MRI contrast agent in situ by genetic means. No bulky-metal complex is required, thereby simplifying intracellular delivery. Our proposal consists of three Specific Aims: (1) we will design second generation MRI reporters for improved sensitivity and minimal reporter sequence length. MRI reporters will be incorporated into replication-defective viral vectors including adenovirus, herpes simplex virus, and vesicular stomatitis virus, for subsequent cell culture and in vivo studies; (2) using the viral vectors we will perform extensive in vitro analyses of the chemical, biochemical, biophysical and toxicological properties of the reporters in established cell lines; (3) we will demonstrate proof-of-principle in vivo by longitudinally imaging the MRI reporters in the CNS of mice. We will quantitatively evaluate their contrasting effects in different tissues via focal injections and by targeting their expression using tissue-specific promoters. Finally, we will look for evidence of pathologic changes in reporter-transduced brain tissues using an array of neuropathological markers. Overall, this platform technology can be adapted to examine gene expression in many tissue types, and thus there are a large number of potential in vivo applications. Examples include preclinical testing of gene therapeutics, such as for the treatment of metastatic disease, and use in transgenic models for drug development. Thus, there is high relevance to the mission of the NIH. Lay Summary - Tools that enable one to visualize gene expression within the living organism are of fundamental importance to the future of medicine and biomedical research. The emerging field of genetic medicine requires non-invasive imaging methods that can indicate if the therapeutic genes have been delivered to the correct cells and if the desired proteins have been made. Towards this goal, our project will develop new technologies to visualize gene expression in vivo using conventional magnetic resonance imaging (MRI) scanners.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Metallo-fluorocarbon nanoemulsion for PET detection of cancer inflammation
-
批准号:10737153
-
项目类别:
-
资助金额:$65.57万
-
财政年份:2023
-
负责人:ERIC T. AHRENS
-
依托单位:
Compositions and methods for enhanced fluorine-19 magnetic resonance imaging cell tracking
-
批准号:9893716
-
项目类别:
-
资助金额:$53.75万
-
财政年份:2017
-
负责人:ERIC T. AHRENS
-
依托单位:
Intracellular oxygen sensing using 19F MRI
-
批准号:8919703
-
项目类别:
-
资助金额:$33.0万
-
财政年份:2013
-
负责人:ERIC T. AHRENS
-
依托单位:
Intracellular oxygen sensing using 19F MRI
-
批准号:8562847
-
项目类别:
-
资助金额:$35.08万
-
财政年份:2013
-
负责人:ERIC T. AHRENS
-
依托单位:
Intracellular oxygen sensing using 19F MRI
-
批准号:8720000
-
项目类别:
-
资助金额:$32.79万
-
财政年份:2013
-
负责人:ERIC T. AHRENS
-
依托单位:
Platform for myocardial infarct MRI and delivery of therapeutics
-
批准号:8395201
-
项目类别:
-
资助金额:$37.92万
-
财政年份:2012
-
负责人:ERIC T. AHRENS
-
依托单位:
IN VIVO VISUALIZATION AND QUANTIFICATION OF EPIGENETIC ACTIVITIES USING MAGNETIC
-
批准号:8145600
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2010
-
负责人:ERIC T. AHRENS
-
依托单位:
IN VIVO VISUALIZATION AND QUANTIFICATION OF EPIGENETIC ACTIVITIES USING MAGNETIC
-
批准号:8141909
-
项目类别:
-
资助金额:$30.56万
-
财政年份:2010
-
负责人:ERIC T. AHRENS
-
依托单位:
CLINICAL TRANSLATION OF 19F MRI TO VISUALIZE CANCER IMMUNOTHERAPEUTIC CELLS
-
批准号:8250461
-
项目类别:
-
资助金额:$42.48万
-
财政年份:2009
-
负责人:ERIC T. AHRENS
-
依托单位:
CLINICAL TRANSLATION OF 19F MRI TO VISUALIZE CANCER IMMUNOTHERAPEUTIC CELLS
-
批准号:7663569
-
项目类别:
-
资助金额:$49.21万
-
财政年份:2009
-
负责人:ERIC T. AHRENS
-
依托单位:
Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
-
批准号:10225356
-
项目类别:
-
资助金额:$45.99万
-
财政年份:2009
-
负责人:ERIC T. AHRENS
-
依托单位:
Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
-
批准号:9384692
-
项目类别:
-
资助金额:$54.05万
-
财政年份:2009
-
负责人:ERIC T. AHRENS
-
依托单位:
Clinical translation of 19F MRI to visualize cancer immunotherapeutic cells
-
批准号:9980334
-
项目类别:
-
资助金额:$50.11万
-
财政年份:2009
-
负责人:ERIC T. AHRENS
-
依托单位:
CLINICAL TRANSLATION OF 19F MRI TO VISUALIZE CANCER IMMUNOTHERAPEUTIC CELLS
-
批准号:8192912
-
项目类别:
-
资助金额:$49.21万
-
财政年份:2009
-
负责人:ERIC T. AHRENS
-
依托单位:
IMAGING CORE
-
批准号:7716549
-
项目类别:
-
资助金额:$62.33万
-
财政年份:2008
-
负责人:ERIC T. AHRENS
-
依托单位:
19F MRI PROBES AND AUTOIMMUNE DISEASE
-
批准号:6869179
-
项目类别:
-
资助金额:$30.49万
-
财政年份:2005
-
负责人:ERIC T. AHRENS
-
依托单位:
NOVEL MARKERS FOR IMAGING GENE EXPRESSION IN VIVO USING MRI
-
批准号:7120551
-
项目类别:
-
资助金额:$32.09万
-
财政年份:2005
-
负责人:ERIC T. AHRENS
-
依托单位:
19F MRI probes and autoimmune disease
-
批准号:7171883
-
项目类别:
-
资助金额:$27.8万
-
财政年份:2005
-
负责人:ERIC T. AHRENS
-
依托单位:
19 FMRI PROBES AND AUTOIMMUNE DISEASE
-
批准号:7009899
-
项目类别:
-
资助金额:$28.63万
-
财政年份:2005
-
负责人:ERIC T. AHRENS
-
依托单位:
19F MRI probes and autoimmune disease
-
批准号:7367810
-
项目类别:
-
资助金额:$27.67万
-
财政年份:2005
-
负责人:ERIC T. AHRENS
-
依托单位:
海外基金